China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- Jingdezhen a 'rare space' for creators, French ceramic artist says
- China revitalizes 88 key rivers, lakes in ecological restoration drive
- La Nina weather pattern could bring extreme cold, droughts, says NCC
- A march of faith: 74-year-old Hong Kong man retraces the Long March on foot
- Tianjin hosts events highlighting status as international destination
- Chinese startup Interphase takes top prize at Kering Generation Award
